Clinical Trials Browser

Phase 1 × Has results × Pluvicto × Clear all

NCT03805594 2025-02-25

177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1 Completed

43 enrolled 20 charts

Prostatic Neoplasms